These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1081 related items for PubMed ID: 27231801

  • 21. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M.
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [Abstract] [Full Text] [Related]

  • 22. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers.
    Surbhi S, Graetz I, Wan JY, Gatwood J, Bailey JE.
    J Manag Care Spec Pharm; 2018 Mar; 24(3):198-207. PubMed ID: 29485952
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Estimation of Missed Statin Prescription Use in an Administrative Claims Dataset.
    Wade RL, Patel JG, Hill JW, De AP, Harrison DJ.
    J Manag Care Spec Pharm; 2017 Sep; 23(9):936-942. PubMed ID: 28854076
    [Abstract] [Full Text] [Related]

  • 25. Nephrotoxic Medication Exposure in U.S. Adults with Predialysis Chronic Kidney Disease: Health Services Utilization and Cost Outcomes.
    Davis-Ajami ML, Fink JC, Wu J.
    J Manag Care Spec Pharm; 2016 Aug; 22(8):959-68. PubMed ID: 27459659
    [Abstract] [Full Text] [Related]

  • 26. Geographic variation in medication adherence in commercial and Medicare part D populations.
    Couto JE, Panchal JM, Lal LS, Bunz TJ, Maesner JE, O'Brien T, Khan T.
    J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
    [Abstract] [Full Text] [Related]

  • 27. Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members.
    Abbass IM, Caplan EO, Ng DB, Kristy R, Schermer CR, Bradt P, Collins JM, Chan WM, Suehs BT.
    J Manag Care Spec Pharm; 2017 Jan; 23(1):27-37. PubMed ID: 28025920
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
    Desai V, Nau D, Conklin M, Heaton PC.
    J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM, Urmie JM, Farris KB, Doucette WR.
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [Abstract] [Full Text] [Related]

  • 35. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS, Gilmer T, Natarajan L, Hovell M.
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [Abstract] [Full Text] [Related]

  • 36. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
    Graff JS, Shih C, Barker T, Dieguez G, Larson C, Sherman H, Dubois RW.
    J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
    [Abstract] [Full Text] [Related]

  • 37. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ.
    J Manag Care Pharm; 2009 Jun; 15(1):18-31. PubMed ID: 19125547
    [Abstract] [Full Text] [Related]

  • 38. Assessment of racial and ethnic inequities in copay card utilization and enrollment in copay adjustment programs.
    Ingham M, Sadik K, Zhao X, Song J, Fendrick AM.
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1084-1092. PubMed ID: 37548953
    [Abstract] [Full Text] [Related]

  • 39. Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older.
    Linton A, Garber M, Fagan NK, Peterson M.
    J Manag Care Pharm; 2007 Oct; 13(8):677-86. PubMed ID: 17970605
    [Abstract] [Full Text] [Related]

  • 40. Benefit restrictions and gout treatment.
    Wang SM, Aranda GA, Gao S, Patel BV.
    J Manag Care Pharm; 2013 Oct; 19(9):773-82. PubMed ID: 24156646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.